Skip to main content

Peer Review reports

From: Phase I non-randomized clinical trial of allogeneic natural killer cells infusion in acute myeloid leukemia patients

Original Submission
17 Jun 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
31 Aug 2023 Reviewed Reviewer Report
3 Sep 2023 Reviewed Reviewer Report
11 Sep 2023 Author responded Author comments - Mohammad Ahmadvand
Resubmission - Version 3
11 Sep 2023 Submitted Manuscript version 3
8 Oct 2023 Author responded Author comments - Mohammad Ahmadvand
8 Oct 2023 Reviewed Reviewer Report
Resubmission - Version 4
8 Oct 2023 Submitted Manuscript version 4
13 Oct 2023 Reviewed Reviewer Report
14 Oct 2023 Author responded Author comments - Mohammad Ahmadvand
Resubmission - Version 5
14 Oct 2023 Submitted Manuscript version 5
18 Oct 2023 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
3 Nov 2023 Editorially accepted
10 Nov 2023 Article published 10.1186/s12885-023-11610-x

You can find further information about peer review here.

Back to article page